Follow
Garrett Dancik
Title
Cited by
Cited by
Year
TERT promoter mutations and telomerase reactivation in urothelial cancer
S Borah, L Xi, AJ Zaug, NM Powell, GM Dancik, SB Cohen, JC Costello, ...
Science 347 (6225), 1006-1010, 2015
3322015
A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment
SC Smith, AS Baras, G Dancik, Y Ru, KF Ding, CA Moskaluk, Y Fradet, ...
The lancet oncology 12 (2), 137-143, 2011
1632011
Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer
ML Nickerson, GM Dancik, KM Im, MG Edwards, S Turan, J Brown, ...
Clinical Cancer Research 20 (18), 4935-4948, 2014
1262014
mlegp: statistical analysis for computer models of biological systems using R
GM Dancik, KS Dorman
Bioinformatics 24 (17), 1966-1967, 2008
103*2008
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
MM Tu, HA Abdel-Hafiz, RT Jones, A Jean, KJ Hoff, JE Duex, ...
Communications Biology 3 (1), 720, 2020
992020
shinyGEO: a web-based application for analyzing gene expression omnibus datasets
J Dumas, MA Gargano, GM Dancik
Bioinformatics 32 (23), 3679-3681, 2016
752016
An osteopontin/CD44 axis in RhoGDI2-mediated metastasis suppression
M Ahmed, JL Sottnik, GM Dancik, D Sahu, DE Hansel, D Theodorescu, ...
Cancer cell 30 (3), 432-443, 2016
722016
Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease
S Guin, C Pollard, Y Ru, C Ritterson Lew, JE Duex, G Dancik, C Owens, ...
Journal of the National Cancer Institute 106 (5), dju062, 2014
712014
Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection
GM Dancik, DE Jones, KS Dorman
Journal of Theoretical Biology 262 (3), 398-412, 2010
572010
A tutor for counter-controlled loop concepts and its evaluation
A Kumar, G Dancik
33rd Annual Frontiers in Education, 2003. FIE 2003. 1, T3C-7, 2003
532003
Biomarkers for prognosis and treatment selection in advanced bladder cancer patients
Y Ru, GM Dancik, D Theodorescu
Current opinion in urology 21 (5), 420-427, 2011
522011
A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors
GM Dancik, CR Owens, KA Iczkowski, D Theodorescu
Stem cells 32 (4), 974-982, 2014
512014
GON4L drives cancer growth through a YY1–androgen receptor–CD24 axis
N Agarwal, GM Dancik, A Goodspeed, JC Costello, C Owens, JE Duex, ...
Cancer research 76 (17), 5175-5185, 2016
422016
Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer
SC Smith, AS Baras, CR Owens, G Dancik, D Theodorescu
Cancer research 72 (14), 3480-3491, 2012
422012
Functional impact of chromatin remodeling gene mutations and predictive signature for therapeutic response in bladder cancer
JE Duex, KE Swain, GM Dancik, RD Paucek, C Owens, MEA Churchill, ...
Molecular Cancer Research 16 (1), 69-77, 2018
362018
Patient mutation directed shRNA screen uncovers novel bladder tumor growth suppressors
J Hensel, JE Duex, C Owens, GM Dancik, MG Edwards, HF Frierson, ...
Molecular Cancer Research 13 (9), 1306-1315, 2015
322015
Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes
GM Dancik, D Theodorescu
PloS one 9 (1), e85249, 2014
322014
A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers
GM Dancik, Y Ru, CR Owens, D Theodorescu
Cancer research 71 (24), 7398-7409, 2011
292011
Nuclear CD24 drives tumor growth and is predictive of poor patient prognosis
JE Duex, C Owens, A Chauca-Diaz, GM Dancik, LA Vanderlinden, ...
Cancer research 77 (18), 4858-4867, 2017
242017
RhoC is an unexpected target of RhoGDI2 in prevention of lung colonization of bladder cancer
EM Griner, GM Dancik, JC Costello, C Owens, S Guin, MG Edwards, ...
Molecular Cancer Research 13 (3), 483-492, 2015
242015
The system can't perform the operation now. Try again later.
Articles 1–20